Erythropoietin for subarachnoid hemorrhage: is there a reason for hope?

Giovanni Grasso, Francesco Tomasello

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

Subarachnoid hemorrhage (SAH) associated with a rupturedcerebral aneurysm remains a source of significant morbidityand mortality, not only from the initial hemorrhage butalso from the delayed complications, such as cerebral vasospasmoften severe enough to induce irreversible changes in cerebralperfusion. Several drugs have been developed that have thepotential to limit cerebral vasospasm and delayed ischemicneurologic deficit, thus improving outcome for patients.
Original languageEnglish
Pages (from-to)46-48
Number of pages3
JournalWorld Neurosurgery
Volume77
Publication statusPublished - 2012

All Science Journal Classification (ASJC) codes

  • Surgery
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Erythropoietin for subarachnoid hemorrhage: is there a reason for hope?'. Together they form a unique fingerprint.

Cite this